Noradrenergic deficits contribute to apathy in Parkinson's disease through the precision of expected outcomes. (2022)
Attributed to:
A new noradrenergic strategy to treat Impulsivity in Progressive Supranuclear Palsy
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.17863/cam.85382
Publication URI: https://www.repository.cam.ac.uk/handle/1810/337976
Type: Journal Article/Review